AR241794A1 - Procedimiento para obtener inteerleucina-2 humana, en una celula de ovario de hamster de la china. - Google Patents

Procedimiento para obtener inteerleucina-2 humana, en una celula de ovario de hamster de la china.

Info

Publication number
AR241794A1
AR241794A1 AR92307511A AR30751192A AR241794A1 AR 241794 A1 AR241794 A1 AR 241794A1 AR 92307511 A AR92307511 A AR 92307511A AR 30751192 A AR30751192 A AR 30751192A AR 241794 A1 AR241794 A1 AR 241794A1
Authority
AR
Argentina
Prior art keywords
chinese hamster
human
interleukin
proceeding
hamster ovary
Prior art date
Application number
AR92307511A
Other languages
English (en)
Spanish (es)
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of AR241794A1 publication Critical patent/AR241794A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/55—IL-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/10—Plasmid DNA
    • C12N2800/108—Plasmid DNA episomal vectors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AR92307511A 1986-05-12 1992-05-08 Procedimiento para obtener inteerleucina-2 humana, en una celula de ovario de hamster de la china. AR241794A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/862,082 US4992367A (en) 1986-05-12 1986-05-12 Enhanced expression of human interleukin-2 in mammalian cells

Publications (1)

Publication Number Publication Date
AR241794A1 true AR241794A1 (es) 1992-12-30

Family

ID=25337602

Family Applications (1)

Application Number Title Priority Date Filing Date
AR92307511A AR241794A1 (es) 1986-05-12 1992-05-08 Procedimiento para obtener inteerleucina-2 humana, en una celula de ovario de hamster de la china.

Country Status (25)

Country Link
US (1) US4992367A (enExample)
JP (1) JPS62278994A (enExample)
AR (1) AR241794A1 (enExample)
AT (1) AT389892B (enExample)
AU (1) AU603576B2 (enExample)
BE (1) BE1000717A5 (enExample)
CH (1) CH675731A5 (enExample)
DE (1) DE3715808A1 (enExample)
DK (1) DK234087A (enExample)
ES (2) ES2006476A6 (enExample)
FI (1) FI872096A7 (enExample)
FR (1) FR2598433B1 (enExample)
GB (1) GB2190382B (enExample)
GR (1) GR870727B (enExample)
HU (1) HU205384B (enExample)
IL (1) IL82475A0 (enExample)
IT (1) IT1215478B (enExample)
LU (1) LU86874A1 (enExample)
MC (1) MC1821A1 (enExample)
NL (1) NL8701132A (enExample)
NO (1) NO871939L (enExample)
NZ (1) NZ220246A (enExample)
PT (1) PT84849B (enExample)
SE (1) SE8701934L (enExample)
ZA (1) ZA872768B (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3014099B2 (ja) * 1987-08-26 2000-02-28 バイオジェン インコーポレイテッド 生物的材料、生物的材料の生産およびこの種の材料の治療への使用方法
FR2619719B1 (fr) * 1987-09-01 1991-05-10 Sanofi Sa Procede d'obtention d'interleukine-2 a partir de cellules eucaryotes, vecteurs necessaires a sa mise en oeuvre et lignees cellulaires hautement productrices
FR2636231A1 (fr) * 1988-09-09 1990-03-16 Sanofi Sa Cellules eucaryotes recombinees productrices d'interleukine-1 (beta) mature n-glycosylee, procede et vecteurs necessaires pour leur obtention et procede d'obtention d'interleukine-1 (beta) mature n-glycosylee
WO1990010069A1 (fr) * 1989-02-28 1990-09-07 Institut Organicheskogo Sinteza Akademii Nauk Latviiskoi Ssr ADN pAA 1213-23 ET pAC 262-33 DE PLASMIDE DE RECOMBINAISON CODANT POUR LA SYNTHESE D'INTERLEUKINE-2 HUMAINE, LEUR PROCEDE DE CONSTRUCTION ET SOUCHE DE BACTERIES ESCHERICHIA COLI RRI/pAC 262-33 EN TANT QUE PRODUCTEUR D'INTERLEUKINE-2 HUMAINE
IL95330A0 (en) * 1989-08-11 1991-06-30 Lilly Co Eli Expression of a functional insect specific toxin gene in mammalian cells
GB9106185D0 (en) * 1991-03-22 1991-05-08 Wellcome Found Biological control agents
US5548075A (en) * 1993-08-30 1996-08-20 Utah State University DNA cassette and transgenic organisms carrying lytic peptide-encoding genes
US5856178A (en) * 1993-08-30 1999-01-05 Utah State University DNA cassettes for expression of lytic peptides in mammalian cells and transgenic organisms containing same
US5641665A (en) * 1994-11-28 1997-06-24 Vical Incorporated Plasmids suitable for IL-2 expression
US5686246A (en) * 1995-08-03 1997-11-11 Kornman; Kenneth S. Detecting genetic predisposition to periodontal disease
CA2231603C (en) 1995-10-17 2009-04-21 Wayne State University Chicken interleukin-15 and uses thereof
US6001613A (en) * 1996-05-24 1999-12-14 Board Of Regents Of University Of Nebraska Plasmid bearing a cDNA copy of the genome of bovine viral diarrhea virus, chimeric derivatives thereof, and method of producing an infectious bovine viral diarrhea virus using said plasmid
AUPP655698A0 (en) 1998-10-16 1998-11-05 Commonwealth Scientific And Industrial Research Organisation Delivery system for porcine somatotropin
US20070025958A1 (en) 2000-10-27 2007-02-01 Hadden John W Vaccine immunotherapy
KR20020043448A (ko) * 2000-12-04 2002-06-10 리송알렉스인근 인터루킨-2 재조합 단백질 및 그의 제조방법
US20040071671A1 (en) * 2001-02-20 2004-04-15 Leturcq Didier J. Cell therapy method for the treatment of tumors
WO2002065992A2 (en) * 2001-02-20 2002-08-29 Ortho-Mcneil Pharmaceutical, Inc. A cell therapy method for the treatment of tumors

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2814039C3 (de) * 1978-03-31 1981-02-19 Gesellschaft Fuer Biotechnologische Forschung Mbh (Gbf), 3300 Braunschweig Verfahren zur Herstellung von Hybrid-Bakterien
US4405712A (en) * 1981-07-01 1983-09-20 The United States Of America As Represented By The Department Of Health And Human Services LTR-Vectors
EP0091539B2 (en) * 1982-03-31 1996-11-27 Ajinomoto Co., Inc. Gene coding for interleukin-2 polypeptide, recombinant DNA carrying said gene, cell lines possessing the recombinant DNA,and method for producing interleukin-2 using said cells
AU556353B2 (en) * 1982-12-15 1986-10-30 Ajinomoto Co., Inc. Interleukin-2 polypeptide
AU579089B2 (en) * 1983-02-08 1988-11-17 Biogen, Inc. Human interleukin-2-like polypeptides
EP0119621A1 (en) * 1983-03-21 1984-09-26 F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft Interleukin-2
WO1985000817A1 (en) * 1983-08-10 1985-02-28 Amgen Microbial expression of interleukin ii
GB8327880D0 (en) * 1983-10-18 1983-11-16 Ajinomoto Kk Saccharomyces cerevisiae
EP0162898A4 (en) * 1983-11-14 1987-07-23 Chiron Corp INTERLEUKIN-2 GENERATION USING CLONED GENES FOR INTERLEUKIN-2 AND YEAR ALPHA FACTOR.
FR2559782B1 (fr) * 1984-02-16 1986-07-18 Transgene Sa Vecteur d'expression dans les levures de l'interleukine-2, levures transformees et procede de preparation de l'interleukine-2
EP0163603B1 (en) * 1984-05-08 1989-12-13 Genetics Institute, Inc. A human t-cell growth factor
DE3419995A1 (de) * 1984-05-29 1985-12-05 Hoechst Ag, 6230 Frankfurt Gentechnologisches verfahren zur herstellung von human-interleukin-2 und mittel zur durchfuehrung dieses verfahrens
EP0172619A1 (en) * 1984-06-20 1986-02-26 Takeda Chemical Industries, Ltd. Novel transformant and use thereof
CA1275954C (en) * 1984-08-31 1990-11-06 Hing Cheug Wong 3'-expression enhancing fragments and method
FR2583770B1 (fr) * 1985-06-21 1988-08-19 Transgene Sa Expression de l'il-2 humaine dans les cellules de mammiferes par un poxvirus recombine
FR2619719B1 (fr) * 1987-09-01 1991-05-10 Sanofi Sa Procede d'obtention d'interleukine-2 a partir de cellules eucaryotes, vecteurs necessaires a sa mise en oeuvre et lignees cellulaires hautement productrices

Also Published As

Publication number Publication date
DE3715808A1 (de) 1987-12-10
FR2598433B1 (fr) 1990-09-21
JPS62278994A (ja) 1987-12-03
AT389892B (de) 1990-02-12
HUT45558A (en) 1988-07-28
PT84849B (pt) 1990-02-08
US4992367A (en) 1991-02-12
MC1821A1 (fr) 1988-03-18
HU205384B (en) 1992-04-28
NO871939D0 (no) 1987-05-11
ATA263787A (de) 1989-07-15
ES2012940A6 (es) 1990-04-16
BE1000717A5 (fr) 1989-03-21
NZ220246A (en) 1990-07-26
PT84849A (pt) 1987-06-01
ZA872768B (en) 1988-04-27
NL8701132A (nl) 1987-12-01
FI872096A0 (fi) 1987-05-12
GB2190382A (en) 1987-11-18
FI872096A7 (fi) 1987-11-13
AU7270387A (en) 1987-11-19
DK234087D0 (da) 1987-05-08
GR870727B (en) 1987-09-21
LU86874A1 (fr) 1988-06-13
ES2006476A6 (es) 1989-05-01
GB8711072D0 (en) 1987-06-17
AU603576B2 (en) 1990-11-22
SE8701934L (sv) 1987-11-13
IT8720479A0 (it) 1987-05-12
SE8701934D0 (sv) 1987-05-11
IL82475A0 (en) 1987-11-30
NO871939L (no) 1987-11-13
CH675731A5 (enExample) 1990-10-31
IT1215478B (it) 1990-02-14
FR2598433A1 (fr) 1987-11-13
GB2190382B (en) 1990-08-15
DK234087A (da) 1987-11-13

Similar Documents

Publication Publication Date Title
ES2059361T3 (es) Complejo de proteinas recombinantes que tiene actividad de factor viii:c su produccion y uso.
DK0559884T4 (da) Rekombinante virusvektorer til ekspression i muskelceller
AR241654A1 (es) Procedimiento para producir activador de plasminogeno de tejido humano.
DE69024291D1 (de) Rezeptoren für Tumornekrosisfaktor-alpha und -beta
ES8505412A1 (es) Un metodo para producir eficazmente un factor de crecimiento similar a insulina humana
ES8401134A1 (es) "metodo de producir un cultivo transformante de celulas de vertebrado".
BR112022016657A2 (pt) Células car-t bcma com atividades melhoradas
KR870000427A (ko) 하이브리드 인터페론의 제조방법
ES8605039A1 (es) Procedimiento para preparar una vacuna que comprende un derivado truncado, libre de una membrana de un tipo fijado a una membrana que tiene determinantes antigenicos expuestos.
CY1109837T1 (el) Διαγνωστικο και θεραπευτικο επιτοπιο
MX9206041A (es) Proceso para producir interferon inmune humano.
PE64396A1 (es) Proteina accesoria del receptor de la interleucina 1
AR125313A1 (es) COMPOSICIONES Y MÉTODOS PARA GENERAR CÉLULAS T a-b A PARTIR DE CÉLULAS MADRES PLURIPOTENTES INDUCIDAS
DE3486474D1 (de) Produkte und Methoden für die Herstellung einer heterodimerer menschlicher LH mit einem Met42 Val55 alpha Untereinheit
MY102594A (en) Expression of plasmodium falciparum polypeptides from cloney cdna
ATE170192T1 (de) Zusammensetzungen und methoden zur synthese des b-rezeptors für das natriuretische protein und verwendungsmethoden
CO5580165A1 (es) Vacunas de rotavirus modificado
DK0628074T3 (da) In vitro aktivering af cytotoksiske T-celler.
ES2012940A6 (es) Un procedimiento para la preparacion de una celula de mamifero capaz de expresar interleukin-2 humana.
ES8801372A1 (es) Un metodo para preparar una vacuna contra el virus de la influenza equina.
NZ234048A (en) Interleukin-7 (il-7) receptor and pharmaceutical compositions
AR246983A1 (es) Plasmido dna recombinante, linea celular y procedimiento para producir beta-ngf humano.
ES2104596T3 (es) Nuevos polipeptidos, secuencias de adn que permiten su expresion, metodo de preparacion, y utilizacion.
ES8600938A1 (es) Un procedimiento para preparar el antigeno de superficie de la hepatitis b
ES2059330T3 (es) Un cdna codificador de antigeno carcinoembrionico.